Tag: Machine learning

augmedix’s-proprietary-notebuilder-tool-leverages-intelligent-automation-technology-to-efficiently-deliver-accurate-and-timely-medical-notes

Augmedix’s Proprietary Notebuilder Tool Leverages Intelligent Automation Technology to Efficiently Deliver Accurate and Timely Medical Notes

global-aircraft-maintenance-tooling-market-forecast-to-2027-–-covid-19-impact-and-analysis

Global Aircraft Maintenance Tooling Market Forecast to 2027 – COVID-19 Impact and Analysis

sound-blaster-gc7:-take-full-control

Sound Blaster GC7: Take Full Control

global-dark-fiber-markets-report-2021-2026:-single-mode-fiber,-multimode-fiber-–-single-mode-fiber-segment-estimated-to-hold-larger-market-share-than-multimode-fiber-segment

Global Dark Fiber Markets Report 2021-2026: Single Mode Fiber, Multimode Fiber – Single Mode Fiber Segment Estimated to Hold Larger Market Share Than Multimode Fiber Segment

worldwide-experiential-networking-industry-to-2026-–-featuring-accedian,-appneta-and-avaya-among-others

Worldwide Experiential Networking Industry to 2026 – Featuring Accedian, AppNeta and Avaya Among Others

nio-inc.-provides-march-and-first-quarter-2021-delivery-update

NIO Inc. Provides March and First Quarter 2021 Delivery Update

bitqt-app-review-–-will-you-make-profit-this-morning-with-this-bitqt-trading-app?

BitQT App Review – Will You Make Profit This Morning With This Bitqt Trading App?

social-life-network-(otc:-wdlf)-to-host-april-5th,-2021-shareholder-update-podcast-for-the-2020-10-k-and-2021-growth-plans

Social Life Network (OTC: WDLF) to Host April 5th, 2021 Shareholder Update Podcast for the 2020 10-K and 2021 Growth Plans

omniq-announces-q4-2020-revenue,-up-12%-yoy-achieving-$13-million-in-q4-revenue;-growth-accelerates-in-q1-2021-with-a-record-$25-million-in-new-orders,-100%-growth-in-ai-based-technology-contracts

OMNIQ Announces Q4 2020 Revenue, up 12% YoY achieving $13 Million in Q4 Revenue; Growth Accelerates in Q1 2021 with a Record $25 Million in New Orders, 100% Growth in AI-Based Technology Contracts

bioxcel-therapeutics-announces-results-of-phase-1b/2-study-of-bxcl501-for-the-treatment-of-opioid-withdrawal-symptoms

BioXcel Therapeutics Announces Results of Phase 1b/2 Study of BXCL501 for the Treatment of Opioid Withdrawal Symptoms